BACKGROUND: Both transforming growth factor (TGF)-beta(1) and activin-A have been implicated in airway remodeling in asthma, but the modulation of their specific signaling pathways after disease activation remains undefined. OBJECTIVE: To define the expression kinetics of TGF-beta(1), activin-A ligands, and follistatin (a natural activin inhibitor), their type I and type II receptors (activin-like kinase[ALK]-1, ALK-5, ALK-4, TbetaRII, and ActRIIA/RIIB) and activation of signaling (via phosphorylated (p) Smad2), in the asthmatic airway after allergen challenge. METHODS: Immunohistochemistry was performed on bronchial biopsies from 15 mild atopic patients with asthma (median age, 25 years; median FEV(1)% predicted, 97%) at baseline and 24 hours after allergen inhalation. Functional effects of activin-A were evaluated by using cultured normal human bronchial epithelial (NHBE) cells. RESULTS: pSmad2(+) epithelial cells increased at 24 hours (P = .03), and pSmad2 was detected in submucosal cells. No modulation of activin-A, follistatin, or TGF-beta(1) expression was demonstrated. Activin receptor(+) cells increased after allergen challenge: ALK-4 in epithelium (P = .04) and submucosa (P = .04), and ActRIIA in epithelium (P = .01). The TGF-beta receptor ALK-5 expression was minimal in the submucosa at baseline and after challenge and was downregulated in the epithelium after challenge (P = .02), whereas ALK-1 and TbetaRII expression in the submucosa increased after allergen challenge (P = .03 and P = .004, respectively). ALK-1 and ALK-4 expression by T cells was increased after allergen challenge. Activin-A induced NHBE cell proliferation, was produced by NHBE cells in response to TNF-alpha, and downregulated TNF-alpha and IL-13-induced chemokine production by NHBE cells. CONCLUSION: Both TGF-beta and activin signaling pathways are activated on allergen provocation in asthma. Activin-A may contribute to resolution of inflammation.
BACKGROUND: Both transforming growth factor (TGF)-beta(1) and activin-A have been implicated in airway remodeling in asthma, but the modulation of their specific signaling pathways after disease activation remains undefined. OBJECTIVE: To define the expression kinetics of TGF-beta(1), activin-A ligands, and follistatin (a natural activin inhibitor), their type I and type II receptors (activin-like kinase[ALK]-1, ALK-5, ALK-4, TbetaRII, and ActRIIA/RIIB) and activation of signaling (via phosphorylated (p) Smad2), in the asthmatic airway after allergen challenge. METHODS: Immunohistochemistry was performed on bronchial biopsies from 15 mild atopicpatients with asthma (median age, 25 years; median FEV(1)% predicted, 97%) at baseline and 24 hours after allergen inhalation. Functional effects of activin-A were evaluated by using cultured normal human bronchial epithelial (NHBE) cells. RESULTS: pSmad2(+) epithelial cells increased at 24 hours (P = .03), and pSmad2 was detected in submucosal cells. No modulation of activin-A, follistatin, or TGF-beta(1) expression was demonstrated. Activin receptor(+) cells increased after allergen challenge: ALK-4 in epithelium (P = .04) and submucosa (P = .04), and ActRIIA in epithelium (P = .01). The TGF-beta receptor ALK-5 expression was minimal in the submucosa at baseline and after challenge and was downregulated in the epithelium after challenge (P = .02), whereas ALK-1 and TbetaRII expression in the submucosa increased after allergen challenge (P = .03 and P = .004, respectively). ALK-1 and ALK-4 expression by T cells was increased after allergen challenge. Activin-A induced NHBE cell proliferation, was produced by NHBE cells in response to TNF-alpha, and downregulated TNF-alpha and IL-13-induced chemokine production by NHBE cells. CONCLUSION: Both TGF-beta and activin signaling pathways are activated on allergen provocation in asthma. Activin-A may contribute to resolution of inflammation.
Authors: Kristian L Jones; Ashley Mansell; Shane Patella; Bernadette J Scott; Mark P Hedger; David M de Kretser; David J Phillips Journal: Proc Natl Acad Sci U S A Date: 2007-10-02 Impact factor: 11.205
Authors: Harsha H Kariyawasam; Maxine Aizen; Julia Barkans; Douglas S Robinson; A Barry Kay Journal: Am J Respir Crit Care Med Date: 2007-02-01 Impact factor: 21.405
Authors: A Rosendahl; D Checchin; T E Fehniger; P ten Dijke; C H Heldin; P Sideras Journal: Am J Respir Cell Mol Biol Date: 2001-07 Impact factor: 6.914
Authors: Hong Wei Chu; Silvana Balzar; Gregory J Seedorf; Jay Y Westcott; John B Trudeau; Phil Silkoff; Sally E Wenzel Journal: Am J Pathol Date: 2004-10 Impact factor: 4.307
Authors: Guoping Li; John Fox; Zhigang Liu; Jun Liu; George F Gao; Yang Jin; Hongwei Gao; Min Wu Journal: J Immunol Date: 2013-10-14 Impact factor: 5.422
Authors: Thomas N Wight; Charles W Frevert; Jason S Debley; Stephen R Reeves; William C Parks; Steven F Ziegler Journal: Cell Immunol Date: 2016-12-23 Impact factor: 4.868
Authors: Jos L J van der Velden; Sidra M Hoffman; John F Alcorn; Jane E Tully; David G Chapman; Karolyn G Lahue; Amy S Guala; Lennart K A Lundblad; Minara Aliyeva; Nirav Daphtary; Charles G Irvin; Yvonne M W Janssen-Heininger Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-03-07 Impact factor: 5.464
Authors: T X Lu; E-J Lim; T Wen; A J Plassard; S P Hogan; L J Martin; B J Aronow; M E Rothenberg Journal: Mucosal Immunol Date: 2012-03-28 Impact factor: 7.313
Authors: Marina Miller; Peter Rosenthal; Andrew Beppu; James L Mueller; Hal M Hoffman; Arvin B Tam; Taylor A Doherty; Matthew D McGeough; Carla A Pena; Maho Suzukawa; Maho Niwa; David H Broide Journal: J Immunol Date: 2014-03-12 Impact factor: 5.422
Authors: Margaret R Spitz; Ivan P Gorlov; Christopher I Amos; Qiong Dong; Wei Chen; Carol J Etzel; Olga Y Gorlova; David W Chang; Xia Pu; Di Zhang; Liang Wang; Julie M Cunningham; Ping Yang; Xifeng Wu Journal: Cancer Discov Date: 2011-08-25 Impact factor: 39.397
Authors: Sofia Tousa; Maria Semitekolou; Ioannis Morianos; Aggelos Banos; Aikaterini I Trochoutsou; Tess M Brodie; Nikolaos Poulos; Konstantinos Samitas; Maria Kapasa; Dimitris Konstantopoulos; Giannis Paraskevopoulos; Mina Gaga; Catherine M Hawrylowicz; Federica Sallusto; Georgina Xanthou Journal: Proc Natl Acad Sci U S A Date: 2017-03-20 Impact factor: 11.205
Authors: Carla P Jones; Lisa G Gregory; Benjamin Causton; Gaynor A Campbell; Clare M Lloyd Journal: J Allergy Clin Immunol Date: 2012-01-24 Impact factor: 10.793
Authors: Charles L Hardy; Susannah J King; Nicole A Mifsud; Mark P Hedger; David J Phillips; Fabienne Mackay; David M de Kretser; John W Wilson; Jennifer M Rolland; Robyn E O'Hehir Journal: Immunol Cell Biol Date: 2015-03-10 Impact factor: 5.126